Clinical Trials Directory

Trials / Conditions / Recurrent Malignant Mesothelioma

Recurrent Malignant Mesothelioma

19 registered clinical trials studyying Recurrent Malignant Mesothelioma.

StatusTrialSponsorPhase
TerminatedHeated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatr
NCT04213794
Mayo ClinicEARLY_Phase 1
TerminatedDonor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapse
NCT03420963
M.D. Anderson Cancer CenterPhase 1
TerminatedTivantinib in Treating Patients With Previously Treated Malignant Mesothelioma
NCT01861301
National Cancer Institute (NCI)Phase 2
CompletedIntrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma
NCT01503177
Mayo ClinicPhase 1
WithdrawnCryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body
NCT01325753
Wake Forest University Health SciencesN/A
CompletedQuality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
NCT01126346
Wake Forest University Health SciencesN/A
WithdrawnAMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma
NCT01105390
National Cancer Institute (NCI)Phase 2
Active Not RecruitingPemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleura
NCT01064648
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedPazopanib in Treating Patients With Malignant Pleural Mesothelioma
NCT00459862
National Cancer Institute (NCI)Phase 2
CompletedSunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma
NCT00392444
National Cancer Institute (NCI)Phase 2
CompletedPXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Rem
NCT00365053
National Cancer Institute (NCI)Phase 2
CompletedCediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery
NCT00309946
National Cancer Institute (NCI)Phase 2
CompletedS0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
NCT00243074
National Cancer Institute (NCI)Phase 2
CompletedSorafenib Tosylate in Treating Patients With Malignant Mesothelioma.
NCT00107432
National Cancer Institute (NCI)Phase 2
CompletedErlotinib in Treating Patients With Malignant Mesothelioma of the Lung
NCT00039182
National Cancer Institute (NCI)Phase 2
CompletedErlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
NCT00030498
National Cancer Institute (NCI)Phase 1
TerminatedEF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for
NCT00028782
National Cancer Institute (NCI)N/A
CompletedCombination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma
NCT00027703
National Cancer Institute (NCI)Phase 2
CompletedGefitinib in Treating Patients With Malignant Mesothelioma
NCT00025207
National Cancer Institute (NCI)Phase 2